surmount 3 tirzepatide 1 // Three-Year Obesty & Diabetes Prevention Outcomes SURMOUNT-3 study design This is

Adding or increasing resistance training often breaks plateaus by improving insulin sensitivity and increasing metabolic rate through muscle preservation

doi: 10.1016/j.bbalip.2022.159262 21

Tirzepatide slows gastric emptying as part of its mechanism, which may feel uncomfortable in a post-bariatric stomach already adapted to rapid transit

When patients stop taking semaglutide, their bodies begin adjusting to the absence of GLP-1 receptor stimulation

This approach gives you complete control over both components without any interaction risk

There is currently no confirmed or announced MHRA/NICE timeline for approving an oral semaglutide option for weight loss